Zhu X - Search Results

1

Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.

Sheng B, Zhao B, Dong Y, Zhang J, Wu S, Ji H, Zhu X. Sheng B, et al. Among authors: zhu x. Carcinogenesis. 2023 Dec 15;44(10-11):748-759. doi: 10.1093/carcin/bgad067. Carcinogenesis. 2023. PMID: 37747823 Free PMC article.

2

Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.

Luo H, Li S, Zhao M, Sheng B, Zhu H, Zhu X. Luo H, et al. Among authors: zhu h, zhu x. Oncotarget. 2017 May 30;8(22):36845-36856. doi: 10.18632/oncotarget.15982. Oncotarget. 2017. PMID: 28415663 Free PMC article. Review.

3

The prognostic values of signal transducers activators of transcription family in ovarian cancer.

Li S, Sheng B, Zhao M, Shen Q, Zhu H, Zhu X. Li S, et al. Among authors: zhu h, zhu x. Biosci Rep. 2017 Jul 16;37(4):BSR20170650. doi: 10.1042/BSR20170650. Print 2017 Aug 31. Biosci Rep. 2017. PMID: 28536310 Free PMC article.

4

Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer.

Zhu H, Chen A, Li S, Tao X, Sheng B, Chetry M, Zhu X. Zhu H, et al. Among authors: zhu x. Biosci Rep. 2017 Sep 27;37(5):BSR20170958. doi: 10.1042/BSR20170958. Print 2017 Oct 31. Biosci Rep. 2017. PMID: 28842515 Free PMC article.

5

Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis.

Shen Z, Luo H, Li S, Sheng B, Zhao M, Zhu H, Zhu X. Shen Z, et al. Among authors: zhu h, zhu x. Oncotarget. 2017 May 29;8(37):62400-62413. doi: 10.18632/oncotarget.18253. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977954 Free PMC article.

6

The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies.

Luo H, Xu X, Ye M, Sheng B, Zhu X. Luo H, et al. Among authors: zhu x. PLoS One. 2018 Jan 30;13(1):e0191972. doi: 10.1371/journal.pone.0191972. eCollection 2018. PLoS One. 2018. PMID: 29381731 Free PMC article.

7

The role of atorvastatin in suppressing tumor growth of uterine fibroids.

Shen Z, Li S, Sheng B, Shen Q, Sun LZ, Zhu H, Zhu X. Shen Z, et al. Among authors: zhu h, zhu x. J Transl Med. 2018 Mar 9;16(1):53. doi: 10.1186/s12967-018-1430-x. J Transl Med. 2018. PMID: 29523174 Free PMC article.

8

Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis.

Song Y, Liu Y, Lin M, Sheng B, Zhu X. Song Y, et al. Among authors: zhu x. Drug Des Devel Ther. 2018 Dec 19;13:79-102. doi: 10.2147/DDDT.S186966. eCollection 2019. Drug Des Devel Ther. 2018. PMID: 30587930 Free PMC article.

9

Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.

Zhu H, Tao X, Zhou L, Sheng B, Zhu X, Zhu X. Zhu H, et al. Among authors: zhu x. BMC Cancer. 2019 Aug 30;19(1):865. doi: 10.1186/s12885-019-6046-x. BMC Cancer. 2019. PMID: 31470801 Free PMC article.

10

Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas.

Shen Q, Zou S, Sheng B, Zhao M, Sun LZ, Zhu X. Shen Q, et al. Among authors: zhu x. Drug Des Devel Ther. 2019 Sep 3;13:3161-3170. doi: 10.2147/DDDT.S212157. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31564832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,502 results

Search Page

Filters